ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 153 filers reported holding ITEOS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $259,526 | -4.1% | 23,701 | +15.9% | 0.00% | – |
| Q2 2023 | $270,732 | -96.2% | 20,448 | -96.1% | 0.00% | -100.0% |
| Q1 2023 | $7,161,000 | +62688.3% | 526,157 | -9.9% | 0.00% | -50.0% |
| Q4 2022 | $11,405 | -99.9% | 583,958 | +7.6% | 0.00% | +100.0% |
| Q3 2022 | $10,342,000 | -10.2% | 542,905 | -2.9% | 0.00% | -50.0% |
| Q2 2022 | $11,522,000 | +57.9% | 559,299 | +146.7% | 0.00% | +100.0% |
| Q1 2022 | $7,295,000 | +166.9% | 226,674 | +286.3% | 0.00% | – |
| Q4 2021 | $2,733,000 | +595.4% | 58,682 | +303.3% | 0.00% | – |
| Q3 2021 | $393,000 | +28.0% | 14,551 | +21.4% | 0.00% | – |
| Q2 2021 | $307,000 | -9.4% | 11,984 | +20.7% | 0.00% | – |
| Q1 2021 | $339,000 | +99.4% | 9,926 | +97.1% | 0.00% | – |
| Q4 2020 | $170,000 | +77.1% | 5,036 | +26.4% | 0.00% | – |
| Q3 2020 | $96,000 | – | 3,984 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
| MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
| Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
| Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
| RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
| Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
| BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
| AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
| Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
| 683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |